Medical Oncology

Doç. Dr. Sema Türker

Doctor and researcher Medical Park Göztepe İstanbul
Breast NeoplasmsStomach NeoplasmsColorectal NeoplasmsBrain NeoplasmsCarcinoma, HepatocellularLiver Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 6 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Stomach Neoplasms 5 publications
  • Colorectal Neoplasms 3 publications
  • Brain Neoplasms 2 publications
  • Carcinoma, Hepatocellular 2 publications
  • Liver Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

  • Meme kanseri
  • Akciğer kanseri
  • Gastrointestinal sistem kanserleri
  • Ürogenital sistem kanserleri
  • Jinekolojik kanserler

CV

Education and experience

From source

Experience

  • 2010 - 2011Polatlı Duatepe Devlet Hastanesi, İç Hastalıkları Uzmanımedicalpark.com.tr
  • 2011 - 2016Marmaris Devlet Hastanesi, İç Hastalıkları Uzmanımedicalpark.com.tr
  • 2014 - 2015Gölcük Necati Çelik Devlet Hastanesi, İç Hastalıkları Uzmanımedicalpark.com.tr
  • 2016Ankara Eğitim Ve Araştırma Hastanesi, İç Hastalıkları Uzmanımedicalpark.com.tr
  • 2016 - 2019Ankara Dışkapı Yıldırım Beyazıt Eğitim Araştırma Hastanesi, Tıbbi Onkoloji Yan Dal Asistanımedicalpark.com.tr
  • 2019 - 2021Zonguldak Bülent Ecevit Üniversitesi, Tıbbi Onkoloji Uzmanımedicalpark.com.tr
  • 2019 - 2021Zonguldak Atatürk Devlet Hastanesi, Tıbbi Onkoloji Uzmanımedicalpark.com.tr

Education

  • 1998 - 2004Ankara Üniversitesi Tıp Fakültesimedicalpark.com.tr
  • 2004 - 2010Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları Uzmanlığımedicalpark.com.tr
  • 2016 - 2019Ankara Dış Kapı Yıldırım Beyazıt Eğitim Araştırma Hastanesi, Tıbbi Onkoloji Uzmanlığı,medicalpark.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologymedicalpark.com.trFrom source
  • Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
  • InstitutionMedical Park Göztepemedicalpark.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 6 publications · Model version —From source
  • Publications48 publicationsOpenAlexFrom source
  • ORCID0000-0001-9040-7266ORCIDFrom source
  • Last synchronised4 November 2026 20:34https://www.medicalpark.com.tr/hekimler/sema-turkermedicalpark.com.tr

Scientific work

Publications on Breast Neoplasms

48 publications

  1. Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study

    Therapeutic Advances in Medical Oncology, 2026

    DOI 10.1177/17588359261430583 PMID 41835339 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  2. Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15041657 PMID 41753346 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15725-9 PMID 41691201 Open-access full textSource: OpenAlex

  4. Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study

    Current Oncology, 2025

    DOI 10.3390/curroncol32110639 PMID 41294701 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  5. Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-19899-3 PMID 41102268 Open-access full textSource: OpenAlex

  6. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2366683 PMID 38904164 1 citation (Europe PMC) Source: OpenAlex

  7. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2305066 PMID 38263804 2 citations (Europe PMC) Source: OpenAlex

  8. Systemic Treatment of Esophageal Cancer

    Springer eBooks, 2024

    DOI 10.1007/978-3-031-47024-0_45 Source: OpenAlex

  9. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

    Journal of Geriatric Oncology, 2023

    DOI 10.1016/j.jgo.2023.101604 PMID 37683369 10 citations (Europe PMC) Open-access full textSource: OpenAlex

View all 48 publications